larrydobrow

Researchers examined the benefits and risks associated with delaying ART initiation to slow bone mineral density loss.

After parathyroidectomy, morbidity and mortality rates were considerably higher in patients with secondary and tertiary vs primary hyperparathyroidism.

Healthy middle-age patients who took colecalciferol did not have a reduced risk for fall or fracture.

Although metformin did not improve glycemic control in patients with type 1 diabetes, the treatment did improve cardiovascular disease risk management.

Gonadotropin-releasing hormone antagonist elagolix demonstrated clinical improvement for women with endometriosis-related pain.

Liraglutide does not increase the risk for acute pancreatitis in patients with type 2 diabetes who are also at high risk for cardiovascular events.

Long-term denosumab increased bone mineral density in postmenopausal women.

No between-group differences for factors such as glycemic control, endogenous glucose production, and insulin sensitivity were found.

Both mealtime and postmeal faster insulin aspart are noninferior to mealtime conventional insulin aspart, regarding HbA1c change from baseline.

After 1 year of therapy, men who underwent testosterone therapy experienced improvement in bone mineral density and mood.

Individuals with low BMI are not at an increased risk for Alzheimer disease.

Women who had taken oral contraceptives for more than 5 years had the lowest risk for fracture.

The fewer menstrual cycles women had over a lifetime placed them at greater risk for incident heart failure.

Thyroid cancer screening in asymptomatic adults was given a D recommendation because of the negative effects of screening outweighing any benefits.

There is a 5% probability of progression from state 1 to state 5 between retinal screenings.

Patients with overweight or obesity with type 2 diabetes had a lower global mean cortical thickness compared with patients at a normal weight.

Researchers conducted a meta-analysis of 70 studies to analyze the prevalence of metabolic syndrome in patients with rheumatoid arthritis.

Gestational diabetes had a 23.3% incidence rate in the combination inositol group compared with 18.3% in the control group.

Patients with diabetes who take anticholinergic medications for overactive bladder may have an increased risk for dementia.

The highest prevalence of metabolic syndrome in women with polycystic ovary syndrome in the United States occurred in black women.

Pregnant women who took lactobacillus rhamnosus HN001 in their second trimester had lower rates of gestational diabetes.

A phase 3a trial evaluates whether the novel glucagon-like peptide-1 analog semaglutide substantially improved glycemic control compared with insulin glargine in patients with type 2 diabetes inadequately controlled with metformin.

A randomized controlled trial assessed whether mild lower extremity compression can be safely used in patients with diabetes and concurrent lower extremity edema.

Study uses data from the Framingham Offspring Cohort to investigate possible relationships between knee osteoarthritis and components of the metabolic syndrome.

A comprehensive systematic review analyzes whether specific sodium-glucose cotransporter 2 inhibitors were more likely to be associated with adverse renal events in patients with type 2 diabetes.

Older patients with diabetes whose hemoglobin A1c levels were greater than 8% had an increased mortality risk.

Data from a large nationwide cohort were used to determine risk of adverse perinatal outcomes in the setting of gestational diabetes.

Cumulative probability of proliferative diabetic retinopathy worsening was 42% in the panretinal photocoagulation group compared with 34% in the ranibizumab group.

Elevated inflammatory markers and active joint disease were both considered risk factors for developing diabetes.

Exercise management for patients with type 1 diabetes should be individualized, depending on insulin concentrations and exercise type/intensity.